NGNermin Güler

Nermin Güler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nermin Güler has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Serum Vitamin D Levels in Asthmatic Children and Adolescents and Its Relationship with Asthma Control

    by Nurhan Özcan Murat, Firdevs Baş, Ümit Mutlu, Nermin Güler, Zeynep Ülker Altınel

    Background: This study aimed to investigate serum 25-hydroxyvitamin D levels in children with asthma and evaluate its association with clinical and laboratory features of asthma, as well as asthma control status.Materials and Methods: Eighty-one asthmatic children (35 girls, 46 boys), aged between 5 and 18 years, who were followed at the Pediatric Allergy Outpatient Clinic, were included. Clinical characteristics, family history of atopy, allergy skin prick test results, pulmonary function test parameters, serum total IgE levels, and peripheral eosinophil percentages were retrospectively obtained from medical records. Asthma control status assessed by both physicians and patients. Blood samples were obtained from all children for the measurement of vitamin D levels. Patients were grouped according to serum vitamin D levels, asthma control status, and treatment regimens.Results: The mean serum vitamin D level was 17.9 ± 8.3 ng/mL. Of the patients, one (1.2%) had severe vitamin D deficiency (20 ng/mL) in 29 (35.8%) patients. No significant relationship was found between serum vitamin D levels and total IgE levels, eosinophil percentages, allergy skin prick test results, or treatment regimens. Similarly, there was no statistically significant association between serum vitamin D levels and asthma control status assessed by either the physician or the patients and their parents. However, vitamin D deficiency was significantly associated with experiencing more than one asthma attack in the past year (p = 0.05).Conclusion: More than half of the asthmatic children included in the study had vitamin D deficiency or insufficiency. Although serum vitamin D levels were not significantly associated with asthma control status, lower levels were linked to an increased risk of frequent asthma attacks.

  • The assessment of exhaled nitric oxide in patients with obesity and asthma before and after exercise

    by Burcu Parlak, Zeynep Ülker Tamay Altinel, Nermin Güler

    It is well known that children who suffer from obesity and asthma may also have exercise-induced bronchospasm. Exhaled nitric oxide is an indicator of airway inflammation, and could be affected by exercise. This study looked at how exercise, which is a typical cause of acute airway obstruction, affects the levels of FeNO and spirometric parameters in obese and asthmatic children. Seventy children between the ages of 6 and 18 were divided into four groups: healthy children, obese children with asthma, obese children without asthma, and normal-weight asthmatic children. FeNO and spirometric parameters were assessed before and after exercise. Their heart rate was raised to 160-170 beats per minute by walking on a flat surface. The highest mean FeNO was seen in the asthmatic-obese group, while the lowest mean FeNO was found in the healthy group. MEF25-75 increased with exercise in the obese non-asthmatic group. FEV1/FVC was the lowest in the asthmatic-obese group. FeNO and FEV1/FVC have a strong association with asthma. The highest values of FeNO found in asthma-obesity combined. It was seen that obesity increased inflammation but exercise did not affect FeNO values. FeNO and FEV1 values were found to be higher in obese patients with and without asthma than normal weight and overweight asthmatics and non-asthmatics.


  • Antibiotic allergy in children with cystic fibrosis: A retrospective case–control study

    by Ayşe Süleyman, Zeynep Tamay, Nermin Güler

    Antibiotic allergy is a big problem that may affect the treatment and life quality of patients with cystic fibrosis (CF).Aim: To evaluate predictive factors for confirmed antibiotic hypersensitivity in children with CF.Methods: In this case–controlled study, we examined 15 patients with CF who had been confirmed with antibiotic allergy. Additionally, we included a control group of age‐ and gender‐matched 45 CF patients with no antibiotic allergy. The diagnosis of antibiotic allergy was confirmed in the presence of a compatible history and a positive response in the drug skin test or provocation test. Multiple drug hypersensitivity was classified according to the temporal relationship of antibiotics: (i) distant, (ii) simultaneous, and (iii) sequential. The data were analyzed by conditional logistic regression.Results: β‐lactam allergy was confirmed in eight patients (ceftazidime n = 5, piperacillin‐tazobactam n = 3) and non‐β‐lactam allergy was confirmed in two patients (ciprofloxacin n = 1, azithromycin n = 1). Additionally, multiple drug hypersensitivity in five patients (distant n = 4, sequential n = 1), among whom two patients showed hypersensitivity against ceftazidime/piperacillin‐tazobactam+ ciprofloxacin/levofloxacin, two patients showed hypersensitivity against ceftazidime+ ciprofloxacin n = 2, and one patient showed hypersensitivity against piperacillin‐tazobactam+ amikacin+ trimethoprim‐sulfamethoxazole. All patients (n = 13) with confirmed β‐lactam allergy were meropenem tolerant. Multivariate analysis indicated that immediate reactions (, p < 0.001) and allergic evaluation in the first six months after the reaction (p = 0.036) were significant risk factors for the prediction of antibiotic hypersensitivity.Conclusion: Beta‐lactam antibiotic allergy is the most commonly confirmed drug allergy in children with CF. However, unlike normal children, ceftazidime and piperacillin‐tazobactam account for the majority.


  • Open Access

    COmparisoN of TastES of Available NutriTional integrated or non-integrated formulas for infants older than 1 year of age with cow’s milk allergy: A multicenter, prospective, single blind, cross-sectional observational clinical study (CONTEST Study)

    by Derya Ufuk Altıntas, Ipek Turktas, Mustafa Arga, Haluk Cezmi Cokugras, Ersoy Civelek, Ozlem Keskin, Betul Buyuktiryaki, Deniz Ertem, Metin Aydogan, Cıgdem Omur Ecevit, et al.

    Palatability of the infant formulas lacking cow milk protein formulas is reported by parents to be an important drawback. The purpose of this study is to examine decisions made by mothers of infants having cow milk protein allergy, and physicians concerning the palatability of unflavored extensively hydrolyzed formulas and amino acid-based formulas. We conducted a multi-center, randomized, single-blinded, observational taste study involving 149 pediatricians from gastroenterology and allergy subspecialties at 14 tertiary healthcare units from different regions of Turkey and involving 94 mothers of infants with cow milk protein allergy. Blinding was performed for seven formulas available in the market, which were the most commonly prescribed for feeding: four AAFs (Neocate-Numil®, Aptamil Pregomin AS-Numil®, Alfamino-Nestle®, Comidagen-Mamma®), one AAF specifically designed to address the growing nutritional and lifestyle needs of children >1 year (Neocate Junior-Numil®), 2 eHFs (Bebelac Pepti Junior-Numil®, Similac Alimentum-Abott®). Considering all three formula characteristics, Neocate junior-Numil® ranked as the number 1 product among seven products by mothers (63.8%) and physicians (69.8%). The ratings of mothers were significantly higher than the physicians (8.1 points and 6.1 points, respectively; p < 0.001). No difference was found in terms of taste, smell, and appearance for Neocate junior-Numil® between the mothers’ and physicians’ ratings. Since caregivers have responsibility for careful selection of replacement products for infants with cow milk protein allergy, it is noteworthy that increased awareness and confidence in the palatability characteristics of these products should motivate mothers and physicians to comply with replacement treatment in the long term.


  • Safety of Cefazolin in Prophylaxis in Β-Lactam Allergic Children

    by Ayşe SÜLEYMAN, Esra Yücel, Zeynep Tamay, Nermin Güler

  • Open Access

    Risk Factors for Immediate-Type Local Anesthetic Hypersensitivity Reactions in Pediatric Patients: A Retrospective Case-Control Study

    by Ayse Suleyman, Zeynep Tamay, Nermin Guler

    Background: Local anesthetics (LA) are relatively safe and rarely cause immediate hypersensitivity reactions. The data on immediate LA hypersensitivity and its risk factors in children are limited. Aim: To evaluate risk factors of immediate LA hypersensitivity. Methods: The retrospective case-controlled study included 17 patients with confirmed immediate LA hypersensitivity. For each patient, three age- and gender-matched control subjects were included in the study. LA hypersensitivity was excluded by skin tests and subcutaneous drug provocation tests in all control subjects. Results: The most common allergic assessment in the patient/control group was for lidocaine (n=5; 29.4%, vs n=23; 45.1%). Suspected LA hypersensitivity reactions were found to be associated with cutaneous manifestations in 14 (82.4%) patients and in 7 (13.7%) of the controls. A history of exposure to local anesthetics twice or more was present in 11 (64.7%) patients vs 6 (11.8%) controls. In conditional regression analysis, repeated LA exposure (≥ 2) and cutaneous findings were determined as significant risk factors (Odds Ratio [OR]:5.7; 95% Confidence Interval [CI]:1.2– 27.1; P=0.029 and (OR:17.3; 95% CI:3.6– 82.5; P< 0.001, respectively). Conclusion: Cutaneous manifestations and a history of LA exposure twice or more were predictive factors for LA allergy confirmed by skin test in children.


  • Open Access

    Evaluation of Suspected Macrolide Allergies in Children

    by Ayşe Süleyman, Esra YücEl, Zeynep Ülker Tamay, Nermin Güler

    Objective: Macrolides are often accepted as safe antibiotics due to their low allergenicity. However, studies on macrolides, particularly studies evaluating cross-reactivity in macrolides, are highly rare in children. This study aimed to evaluate the clinical manifestations, confirmation rate, and frequency of cross-reactivity in children admitted with suspicious clarithromycin or azithromycin allergy. Materials and Methods: A total of 61 children suspected of macrolide antibiotic allergy (clarithromycin, n = 39 and azithromycin, n = 22) were evaluated. Allergy work-up including drug provocation tests were performed in all patients to confirm drug allergy. Results: Macrolide allergy was confirmed in 9.8% (n = 6) of patients (azithromycin, 18.2% [n = 4] and clarithromycin, 5.1% [n = 2]). There was no significant difference between the confirmation rate of clarithromycin and azithromycin (P = .117). Cross-reaction with clarithromycin was confirmed in 2 (33.3%) patients with azithromycin allergy. Conclusion: Drug skin tests are not capable of confirming or ruling out macrolide allergy, and oral provocation tests are essential for a definitive diagnosis. Cross-reactivity, albeit rare, can occur between clarithromycin and azithromycin, which are the most frequently used macrolides in children. Cite this article as: Süleyman A, Yücel E, Tamay ZÜ, Güler N. Evaluation of suspected macrolide allergies in children. Turk Arch Pediatr. 2022;57(1):81-86.


  • Food-induced anaphylaxis in early childhood and factors associated with its severity

    by Metin Aydogan, Erdem Topal, Nalan Yakıcı, Hazal Cansu Acar, Zeynep Hızlı Demirkale, Mustafa Arga, Pınar Uysal, Sezin Aydemir, Isıl Eser Simsek, Zeynep Tamay, et al.

    Background:Several factors that increase the risk of severe food-induced anaphylaxis have been identified.Objective:We aimed to determine the demographic, etiologic, and clinical features of food-induced anaphylaxis in early childhood and also any other factors associated with severe anaphylaxis.Methods:We carried out a medical chart review of anaphylaxis cases from 16 pediatric allergy and immunology centers in Turkey.Results:The data of 227 patients with 266 food-induced anaphylaxis episodes were included in the study. The median (interquartile range) age of the first anaphylaxis episode was 9 months (6‐18 months); 160 of these patients were boys (70.5%). The anaphylaxis episodes were mild in 75 cases (28.2%), moderate in 154 cases (57.9%), and severe in 37 cases (13.9%). The most frequent food allergens involved were cow's milk (47.4%), nuts (16.7%), and hen's egg (15.8%). Epinephrine was administered in only 98 (36.8%) of these anaphylaxis episodes. A logistic regression analysis revealed two statistically significant factors that were independently associated with severe anaphylaxis: the presence of angioedema and hoarseness during the anaphylactic episode. Urticaria was observed less frequently in patients who developed hypotension. In addition, confusion and syncope were associated with 25.9- and 44.6-fold increases, respectively, in the risk of concomitant hypotension.Conclusion:Cow's milk, nuts, and hen's egg caused the majority of mild and moderate-to-severe anaphylaxis episodes. The presence of angioedema and hoarseness in any patient who presents with a history of food-induced anaphylaxis should alert clinicians that the reaction may be severe. In addition, the presence of confusion, syncope, or stridor probably indicates concomitant hypotension.


  • Open Access

    OKUL ÖNCESİ ASTIMLI ÇOCUKLARDA YATMADAN ÖNCEKİ BESLENME: ÜST SOLUNUM YOLU SEMPTOMLARINI VE ASTIM KONTROLÜNÜ ETKİLER Mİ?

    by Ayşe Süleyman, Esra Özek Yücel, Zeynep Hızlı Demirkale, Sevgi Sipahi Çimen, Cevdet Özdemir, Zeynep Altınel, Nermin Güler


  • Clarithromycin hypersensitivity in children: Is there a link with β‐lactam hypersensitivity?

    by Ayse Suleyman, Esra Yucel, Sevgi Sipahi Cimen, Zeynep Hizli Demirkale, Cevdet Ozdemir, Zeynep Ulker Tamay, Nermin Guler

    Background: Clarithromycin hypersensitivity is reported as the most common cause of non‐β‐lactam antibiotic allergy in children. Clarithromycin is frequently prescribed in cases of suspected β‐lactam hypersensitivity. Oral provocation tests stand as the gold standard to confirm drug hypersensitivity as diagnostic value of skin tests is variable. We analyzed the frequency of true clarithromycin hypersensitivity ratio and its relationship with β‐lactam allergy among children with suspected clarithromycin hypersensitivity and evaluated the diagnostic value of skin tests.Methods: The study included 160 children referred with suspected clarithromycin hypersensitivity. Clinical history and allergy workups including skin tests or/and oral provocation tests were retrieved from medical records.Results: Oral provocation test confirmed clarithromycin hypersensitivity rate was 5.6% (n = 9/160). Skin tests with clarithromycin showed positivity in 32.6% (n = 29/89) of the tested patients. The sensitivity of clarithromycin skin tests was negligible, and specificity was 73.9% (95% confidence interval [CI], 64.7–81.8). Eighty‐eight of the patients (55%) reported that they had previously tolerated a β‐lactam antibiotic. β‐lactam hypersensitivity was suspected in 40% (n = 64/160) of the patients (simultaneous [n = 10], sequential [n = 19], distant form [n = 35]) in relation with clarithromycin usage. β‐lactam hypersensitivity (95% CI, 2.1–70.6,p = .005) and sequential usage of clarithromycin after the development of a rash with amoxicillin‐clavulanic acid (95% CI, 2.0–96.4,p = .007) were found as risk factors for confirmed clarithromycin hypersensitivity.Conclusion: The frequency of confirmed clarithromycin hypersensitivity was found low among suspected patients. Oral provocation test is crucial for definite diagnosis. Confirmed β‐lactam allergy may be attributed as a risk factor for clarithromycin hypersensitivity, particularly clarithromycin treatment after a developing rash with amoxicillin‐clavulanic acid in sequential usage.